News

Article

£200m+ invested in Babraham Campus companies, what lies ahead?

Read about the Babraham Investor Conference 2021 focusing on early-stage and scale-up life science and med-tech companies.

18.07.2021

Published by Business Weekly

Read about the Babraham Investor Conference 2021 focusing on early-stage and scale-up life science and med-tech companies.

Published by Business Weekly

Read now

Article

How the body's building blocks will revolutionise medicine

This piece focuses on the promise of stem cells for cell therapies.

28.06.2021

Published by MoneyWeek

Read now

Article

Davide Danovi, Head of Cellular Phenotyping talks at Sci Foo

Sci Foo Camp is run by Digital Science, Google, Nature Publishing Group and O’Reilly Media.

28.06.2021

Published by Sci Foo

Read now

Podcast

Founder and CEO Dr Mark Kotter talks reprogrammed human cells for research and drug development

The conversation covers our opti-ox technology and its potential for cell therapies.

28.06.2021

Published by Bioinformatics

Read now

Podcast

The story of bit.bio on the Healthtech Podcast

The conversation covers the promise of reprogrammed human cells for therapies and drug discovery.

09.06.2021

Published by Healthtech podcast

Read now

Article

CEO and founder Mark Kotter on Spectator TV about cultured meat

Cindy Yu talks to Mark Kotter about cultured meat and its possible impact on sustainability.

02.06.2021

Published by Spectator TV

Read now

Article

bit.bio cell revolution looks to transform dementia treatments & grow organs

The piece covers potential treatments for dementia and muscular dystrophy with engineered human cells.

19.05.2021

Published by Daily Express

Read now

Article

bit.bio’s Mark Kotter: “A single cell to feed the world”

bit.bio CEO and founder Dr Mark Kotter was a speaker on the podcast Danny in the Valley.

13.05.2021

Published by The Sunday Times

Read now

Related pages